# A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis

> **NCT07422532** · NA · NOT_YET_RECRUITING · sponsor: **Imperial College London** · enrollment: 84 (estimated)

## Conditions studied

- Type 2 Diabetes
- Chronic Kidney Disease 5D

## Interventions

- **DEVICE:** Omnipod 5
- **DEVICE:** Insulin injections

## Key facts

- **NCT ID:** NCT07422532
- **Lead sponsor:** Imperial College London
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-01
- **Primary completion:** 2027-04-01
- **Final completion:** 2027-04-01
- **Target enrollment:** 84 (ESTIMATED)
- **Last updated:** 2026-02-20

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07422532

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07422532, "A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07422532. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*